Diagnosing invasive fungal diseases - limitations of microbiological diagnostic methods.

about

Utility of PCR in diagnosis of invasive fungal infections: real-life data from a multicenter study.Laboratory diagnosis of mucormycosis: current status and future perspectives.Invasive candidiasis: future directions in non-culture based diagnosis.

P2860

Q30583368-64DA23DA-5623-4417-8C96-8E902431BF56 Q35193540-9CA1B931-8A9F-4E69-965A-8AE31A28ADC5 Q38614492-5FF9EAEF-EDEC-42AE-B12A-04BDECC8C969

P2860

Diagnosing invasive fungal diseases - limitations of microbiological diagnostic methods.

Item

http://www.wikidata.org/entity/Q38088858

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Diagnosing invasive fungal diseases - limitations of microbiological diagnostic methods.

@en

type

Item

label

Diagnosing invasive fungal diseases - limitations of microbiological diagnostic methods.

@en

prefLabel

Diagnosing invasive fungal diseases - limitations of microbiological diagnostic methods.

@en

P1476

Diagnosing invasive fungal diseases - limitations of microbiological diagnostic methods.

@en

P2093

Astrid Mayr

http://www.w3.org/2001/XMLSchema#string

P2860

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

Detection of gliotoxin in experimental and human aspergillosis

Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.

Current status of nonculture methods for diagnosis of invasive fungal infections

Fluorescence in situ hybridization with peptide nucleic acid probes for rapid identification of Candida albicans directly from blood culture bottles

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

Utilization of the internal transcribed spacer regions as molecular targets to detect and identify human fungal pathogens.

Diagnosis of histoplasmosis by antigen detection based upon experience at the histoplasmosis reference laboratory.

P304

461-470

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17530050902878031

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Cornelia Lass-Flörl

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23485213

http://www.w3.org/2001/XMLSchema#string

Diagnosing invasive fungal diseases - limitations of microbiological diagnostic methods.

about

P2860

P2860

Diagnosing invasive fungal diseases - limitations of microbiological diagnostic methods.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698